Abano Healthcare Group Limited provided financial guidance for the six months ending September 30,2017. For the period, the company expects gross revenue in the range of $155 million to $160 million, revenue in the range of $130 million to $135 million, EBITDA in the range of $17.1 million to $18.3 million, underlying EBITDA in the range of $17.5 million to $18.7 million, NPAT in the range of $5.4 million to $6.2 million and underlying NPAT in the range of $6.3 million to $7.1 million.